Beyond Air (XAIR) Total Debt Growth (1y) (2016 - 2026)
Analysis
Beyond Air (XAIR) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 12.29% |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | 127.30% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 127.30% |
| Mar 31, 2026 | 124.76% |
| Dec 31, 2025 | 150.56% |
| Sep 30, 2025 | -9.94% |
| Jun 30, 2025 | -36.35% |
| Mar 31, 2025 | -36.82% |
| Dec 31, 2024 | -39.56% |
| Sep 30, 2024 | -21.80% |
| Jun 30, 2024 | 8.69% |
| Mar 31, 2024 | 955.85% |
| Dec 31, 2023 | 218.20% |
| Sep 30, 2023 | 197.69% |
| Jun 30, 2023 | 65.26% |
| Mar 31, 2023 | -83.53% |
| Dec 31, 2022 | 1,370.97% |
| Sep 30, 2022 | 2.80% |
| Jun 30, 2022 | 77.54% |
| Mar 31, 2022 | 77.51% |
| Dec 31, 2021 | -94.36% |
| Sep 30, 2021 | 4.21% |